Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-03-03

FDA Approved: CHILDREN ALLERGY — Supplemental Application (Walgreens)

View source ↗

Summary

FDA approved a supplemental application for a pediatric allergy indication using fexofenadine hydrochloride (Children's Allergy), expanding the product’s labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Children Allergy (Fexofenadine hydrochloride)

Snippet

SUPPL AP for CHILDREN ALLERGY (FEXOFENADINE HCL)